Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Meghan Frances Moore Burk

TitleLecturer
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-PM&R Physical Therapy
Phone925/389-0264

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Yang ML, Apkon S, Kelley C, Moore Burk M, Silver C, Johnson K, De S, Harrington E, Wheeler A, Homme A, Murphy-Zane MS. Transcranial Motor-Evoked Potentials Provide More Reliable Intraoperative Neuromonitoring Than Somatosensory-Evoked Potentials in Charcot-Marie-Tooth Patients Undergoing Periacetabular Osteotomy for Hip Dysplasia. J Pediatr Soc North Am. 2026 Aug; 16:100381. PMID: 42291697.
      View in: PubMed
    2. Krosschell KJ, Dunaway Young S, Maczek E, Brown L, Hoffman K, Corbo Galli C, Muni Lofra R, Coratti G, Moore Burk M, Townsend EL, Kelley C, Weigel C, Civitello M, Kanner CH, McIntyre M, Nelson L, Rao V, Castro D, Farrar M, Kuntz NL, Apkon SD, Zolkipli-Cunningham Z. Navigating new motor function trajectories: Consensus recommendations for assessment in the era of newborn screening and early treatment in SMA. J Neuromuscul Dis. 2026 Apr 07; 22143602261433638. PMID: 41944185.
      View in: PubMed
    3. Moore Burk M, Crawford TO, Johnson K, Apkon S, Brown L, Carry T, Hoffman K, Kelley C, Kuntz NL, Miller J, Nance J, Patel R, Rao V, Rothman C, Schwaede A, Stratton A, Thinger S, Trenkle J, Van Os M, Vela K, Duong T, Krosschell KJ. New SMA era: A broad-range tiered assessment of function for the evolving SMA phenotype (EVOLVE-SMA). J Neuromuscul Dis. 2026 Jul; 13(4):748-768. PMID: 41467984.
      View in: PubMed
    4. Moore Burk M, Kelley C, Browning K, Stratton A, Apkon S, Wright M, Yang ML. Letter to the editor: A case of spinal muscular atrophy type 0 treated with nusinersen without progression of early-onset scoliosis. Brain Dev. 2025 Oct; 47(5):104411. PMID: 40737882.
      View in: PubMed
    5. Van Hove JLK, Friederich MW, Hock DH, Stroud DA, Caruana NJ, Christians U, Schniedewind B, Michel CR, Reisdorph R, Lopez Gonzalez EDJ, Brenner C, Donovan TE, Lee JC, Chatfield KC, Larson AA, Baker PR, McCandless SE, Moore Burk MF. ACAD9 treatment with bezafibrate and nicotinamide riboside temporarily stabilizes cardiomyopathy and lactic acidosis. Mitochondrion. 2024 Sep; 78:101905. PMID: 38797357.
      View in: PubMed
    Moore Burk's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (20) concept(s)
    _
    Co-Authors Expand Description
    See all (14) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)